NK Cells & COVID-19

NK Cells & COVID-19

The first-in-human study evaluates the safety and potential efficacy of natural killer cells to treat patients with moderate COVID-19 disease. The clinical trial involves infusions of CYNK-001, NK cells formulated from human placental stem cells donated after birth....
NK cells to the rescue of COVID-19

NK cells to the rescue of COVID-19

Natural killer (NK) cells, as a part of innate immune system, play an important role during acute viral infection. Before specific immunity develops, NK cells are the first to respond to infected cells. Previous studies reported that COVID-19 patients have lower than...